|
|||||
|
|
MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation |
|
| Authors: | Y. Wang W. Deng Y. Zhang S. Sun S. Zhao Y. Chen X. Zhao L. Liu J. Du |
| Affiliation: | 1. Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China;2. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China;3. Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China |
| Abstract: | |
| Keywords: | breast cancer cell migration epidermal growth factor receptor MICAL2 P38 |